# Gilead Sciences: what changed between 2025-11-08 and 2026-11-08 entity: /record/gilead-sciences.md from: 2025-11-08 to: 2026-11-08 page: /record/gilead-sciences/diff?from=2025-11-08&to=2026-11-08 json: /v1/entities/gilead-sciences/diff?from=2025-11-08&to=2026-11-08 Between 2025-11-08 and 2026-11-08, Gilead Sciences's record changed in 15 facts: 3 replaced (net income $480 million → $8.51 billion; operating income $1.66 billion → $10.02 billion; revenue $28.75 billion → $29.44 billion), 6 added, 6 ended; 12 unchanged. State as of 2025-11-08: /record/gilead-sciences.md?as_of=2025-11-08 · as of 2026-11-08: /record/gilead-sciences.md?as_of=2026-11-08. Format: subject | predicate | value | valid range | confidence | status | claim. Posts and Hugging Face repos are left out (0 held on 2025-11-08, 0 on 2026-11-08). ## Replaced (3) The same fact with a different value: the claim that held on the earlier day, then the one that holds on the later day. - net income: $480 million → $8.51 billion - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 480,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_075AC6F097D8](/claim/clm_075AC6F097D8.md) | [clm_D66A9204BCB4](/claim/clm_D66A9204BCB4.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209525000006/0000882095-25-000006-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | net_income | 8,510,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_075AC6F097D8](/claim/clm_075AC6F097D8.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/0000882095-26-000006-index.htm - operating income: $1.66 billion → $10.02 billion - [Gilead Sciences](/record/gilead-sciences.md) | operating_income | 1,662,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_44AE227A69DA](/claim/clm_44AE227A69DA.md) | [clm_9D8D94D516C5](/claim/clm_9D8D94D516C5.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209525000006/0000882095-25-000006-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | operating_income | 10,022,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_44AE227A69DA](/claim/clm_44AE227A69DA.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/0000882095-26-000006-index.htm - revenue: $28.75 billion → $29.44 billion - [Gilead Sciences](/record/gilead-sciences.md) | revenue | 28,754,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_5E2D1C5DC1DC](/claim/clm_5E2D1C5DC1DC.md) | [clm_766F0DC2656D](/claim/clm_766F0DC2656D.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209525000006/0000882095-25-000006-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | revenue | 29,443,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_5E2D1C5DC1DC](/claim/clm_5E2D1C5DC1DC.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/0000882095-26-000006-index.htm ## Added (6) Held on 2026-11-08, not on 2025-11-08. - [Gilead Sciences](/record/gilead-sciences.md) | quarterly_net_income | 2,429,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_4B6581046BE2](/claim/clm_4B6581046BE2.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209526000039/0000882095-26-000039-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | quarterly_operating_income | 3,462,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_8490C244F9F5](/claim/clm_8490C244F9F5.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209526000039/0000882095-26-000039-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | quarterly_revenue | 8,300,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_64E20B8C7E0A](/claim/clm_64E20B8C7E0A.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209526000039/0000882095-26-000039-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | shares_outstanding | 1,240,338,614 shares | valid 2026-10-23 to present | conf 0.95 | valid | [clm_3ADDE79BC725](/claim/clm_3ADDE79BC725.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209526000039/0000882095-26-000039-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | total_assets | 51,408,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_53C30342724D](/claim/clm_53C30342724D.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209526000039/0000882095-26-000039-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | total_equity | 13,040,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_F5C77DE07AFE](/claim/clm_F5C77DE07AFE.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209526000039/0000882095-26-000039-index.htm ## Ended (6) Held on 2025-11-08, not on 2026-11-08, and not replaced by another value. - [Gilead Sciences](/record/gilead-sciences.md) | quarterly_net_income | 3,052,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_24FF1FC3A935](/claim/clm_24FF1FC3A935.md) | [clm_8C716505DCB2](/claim/clm_8C716505DCB2.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209525000047/0000882095-25-000047-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | quarterly_operating_income | 3,327,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_3305AD308056](/claim/clm_3305AD308056.md) | [clm_E88E046C7258](/claim/clm_E88E046C7258.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209525000047/0000882095-25-000047-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | quarterly_revenue | 7,769,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_5B00A751741D](/claim/clm_5B00A751741D.md) | [clm_3A5203A42518](/claim/clm_3A5203A42518.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209525000047/0000882095-25-000047-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | shares_outstanding | 1,240,679,623 shares | valid 2025-10-31 to 2026-02-13 | conf 0.95 | superseded | superseded_by [clm_E2DB5E0B53B4](/claim/clm_E2DB5E0B53B4.md) | [clm_5E452E3F3A54](/claim/clm_5E452E3F3A54.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209525000047/0000882095-25-000047-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | total_assets | 58,533,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_06C160F8C3A5](/claim/clm_06C160F8C3A5.md) | [clm_5B9243C901AF](/claim/clm_5B9243C901AF.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209525000047/0000882095-25-000047-index.htm - [Gilead Sciences](/record/gilead-sciences.md) | total_equity | 21,540,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_994B784F55A6](/claim/clm_994B784F55A6.md) | [clm_B2A4004D2607](/claim/clm_B2A4004D2607.md) sources: https://www.sec.gov/Archives/edgar/data/882095/000088209525000047/0000882095-25-000047-index.htm ## Unchanged 12 claims held on both days: cash_and_equivalents 1, cik 1, fiscal_year_end 1, headquarters 1, listed_on 1, quarterly_research_and_development 1, registrant_name 1, research_and_development 1, sic_industry 1, state_of_incorporation 1, ticker 1, website 1. ## Get this data - JSON: /v1/entities/gilead-sciences/diff?from=2025-11-08&to=2026-11-08 - MCP: entity_diff(entity: "gilead-sciences", from: "2025-11-08", to: "2026-11-08") - Entity twin: /record/gilead-sciences.md · timeline: /timelines/gilead-sciences.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.